Why do relapse rates differ when ADHD is untreated?Â
People with untreated ADHD face much higher risks, in addiction, mental health, and even daily life stability, than those receiving consistent care. According to a PMC 2025 and NHS England’s ADHD Taskforce, untreated ADHD drives cycles of stress, impulsivity, and repeated crisis, while active treatment helps break the pattern.
How untreated ADHD fuels relapse
Untreated ADHD affects brain regions involved in reward, motivation, and self-control. NICE guidance explains that these neurobiological differences increase the likelihood of impulsive or risky behaviour, particularly under stress or emotional strain. Without diagnosis or support, many people turn to substances, gambling, or other short-term coping strategies that reinforce relapse cycles.
Social and behavioural pressures add to this risk. People living with untreated ADHD often experience unstable relationships, employment difficulties, and financial stress, all of which make maintaining recovery harder. The NHS ADHD Taskforce (2025) found that unsupported ADHD contributes to higher A&E attendance, justice involvement, and unmet mental health needs.
What the evidence shows
A BMJ study (2025) found that ADHD medication significantly reduced relapse rates across substance misuse, suicidal behaviour, and accidents compared with untreated ADHD groups. Research published in PubMed and the Royal College of Psychiatrists’ CR235 guidance confirms that relapse, recurrence, and adverse life outcomes are far more common when ADHD remains untreated, especially during major transitions such as early adulthood or recovery from addiction.
Both NICE and NHS policy recommend early identification, consistent treatment, and joined-up care between ADHD and addiction teams to prevent recurring crises and long-term harm.
Breaking the relapse cycle
Effective ADHD management, whether through medication, behavioural therapy, or psychological support, stabilises the brain pathways that drive relapse. Shared care and integrated approaches, now promoted across NHS services, ensure safe prescribing, regular review, and holistic recovery support.
Private and NHS pathways alike, including ADHD Certify, follow these NICE-aligned frameworks, providing evidence-based assessments and medication reviews within structured, monitored care plans.
Takeaway
Untreated ADHD does not just make life harder; it significantly increases relapse risk across health, social, and behavioural areas. According to NICE, NHS England, evidence, early recognition and consistent treatment are key to preventing repeated crises and improving long-term recovery and quality of life.
